Showing results (1-10 of 3) with videos related to
Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2010
Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanomaJohn M Kirkwood, Paul Lorigan, Peter Hersey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Randomized phase II study of dacomitinib (PF-00299804), an irreversible pan-human epidermal growth factor receptor inhibitor, versus erlotinib in patients with advanced non-small-cell lung cancerSuresh S Ramalingam, Fiona Blackhall, Maciej Krzakowski, et al.The Lancet. Oncology|December 3, 2014
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trialSuresh S Ramalingam, Pasi A Jänne, Tony Mok, et al.Pageof 1